STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #319 by analyst upside · 2026-06-27
SCNX
Scienture Holdings, Inc.
Healthcare · Market Cap $15M · P/E 0x
ANALYST PRICE TARGET
+316.4%
implied upside to consensus target
Current Price $0.36
Consensus Target $1.5
Bull Target $1.5
Bear Target $1.5
Analysts Covering 1
ANALYST CONSENSUS - STRONG BUY
Strong Buy
1
Buy
0
Hold
0
Sell
0
52-Week Low $0.24
52-Week High $2.6
YTD Return -30.9%
FUNDAMENTALS
Market Cap $15M
P/E Ratio (TTM) N/A
Forward P/E -6.0x
EPS (TTM) $-2.45
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $0M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $0.24
52-Week High $2.6
Current Price $0.36
Bear Target $1.5
Bull Target $1.5
● Now $0.36 ● Target $1.5
TRADING DATA
Avg Volume 537K
YTD Return -30.9%
Analyst Count 1
Consensus Strong Buy
Upside to Target +316.4%
Last Updated 2026-06-27

ANALYST SUMMARY

Scienture Holdings, Inc. (SCNX) is currently trading at $0.36 with a Wall Street consensus price target of $1.5, implying potential upside of 316.4% over the next 12 months. 1 analysts currently cover SCNX, with a consensus rating of Strong Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $1.5, while the most cautious has a target of $1.5.

SCNX operates in the Healthcare sector with a market capitalisation of $15M. The stock is down 30.9% year-to-date and is currently trading near the lower end of its 52-week range of $0.24 – $2.6.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for SCNX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Maxim Group ● Initiated
Buy 2026-02-24 28% win rate (40 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
5/30
Consensus clarity
8/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →